π¬ Current Disease Focus:
Task Progress: 0%
π₯ Active Problem Solvers
0
π Experts collaborating globally
β‘ Current Task Assignment
𧬠Genetic Analysis
π Matching experts to specific tasks
π Resource Allocation by Research Phase:
π Data Analysis
π§ͺ Experimental Design
π¬ Clinical Trials
π Treatment Development
This is a phase 1, first-in-human (FIH), open-label, multicohort study to e...
Status
Completed
Location
Institute of Hematology & Blood Diseases Hospital
Start Date
2023-07-31
Trial ID
NCT05987696
Treatments Being Tested
This is a single arm, open-label, early phase β study, to determine the saf...
Status
Unknown
Location
Hunan Provincial People's Hospital
Start Date
2019-03-21
Trial ID
NCT03910842
Treatments Being Tested
This example phase 1/2, open-label, biomarker-selected study evaluates EB-H...
Status
Recruiting
Location
Peking University Shenzhen Hospital
Start Date
2026-03-02
Trial ID
NCT07641036
Treatments Being Tested
This is a Phase 1/2, open-label, multi-center, multi-cohort, non-randomized...
Status
Recruiting
Location
Nkarta Investigational Site
Start Date
2024-06-13
Trial ID
NCT06557265
Treatments Being Tested
T effector cells and NK cells have mutual compensatory killing functions on...
Status
Recruiting
Location
The Second Affiliated Hospital of Guangzhou Medical University
Start Date
2019-01-01
Trial ID
NCT03882840
Treatments Being Tested
This study is an open, exploratory clinical study to evaluate the safety an...
Status
Recruiting
Location
The Second Affiliated Hospital of Guangzhou Medical University
Start Date
2022-06-01
Trial ID
NCT05410717
Treatments Being Tested
This is a Phase I dose-finding study of FT576 as monotherapy and in combina...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2021-11-10
Trial ID
NCT05182073
To find the highest tolerable dose of dualCAR-NK19/70 (a type of cell thera...
Status
Recruiting
Location
Shanghai Tongji Hospital, Tongji University School of Medicine
Start Date
2023-01-18
Trial ID
NCT05842707
Treatments Being Tested
This phase 1/2 study is testing a new treatment for acute myeloid leukemia ...
Status
Not Yet Recruiting
Location
Nationwide Children's Hospital
Start Date
2026-04-01
Trial ID
NCT07026942
Treatments Being Tested
This study is a single-center, open-label, single-arm, dose-escalation tria...
Status
Recruiting
Location
the second affiliated hospital Zhejiang University School of Medicine
Start Date
2025-01-06
Trial ID
NCT06614270
Treatments Being Tested